Composed Abdominal Wall Analysis. Collecting Tissue and Blood From Patients Undergoing Elective Laparosopic Cholecystectomy. Objective to Describe the Normal Abdominal Wall
Launched by REGION VÄSTERBOTTEN · Nov 29, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Individuals seeking planned care for surgery on their gallbladder due to gallstone disease
- Exclusion Criteria:
- • Disseminated cancer,
- • Ongoing acute inflammation of the gallbladder,
- • Known connective tissue disease,
- • Cortisone medication,
- • BMI \>35,
- • Clinically measured rectus diastasis of \>4 cm and/or concurrent abdominal wall hernia
- • Patients operated for abdominal wall hernia
About Region Västerbotten
Region Västerbotten is a leading healthcare authority in northern Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Västerbotten focuses on collaborating with academic institutions, industry partners, and healthcare professionals to facilitate groundbreaking studies that address critical health challenges. With a commitment to ethical standards and patient safety, the organization aims to contribute to the global body of medical knowledge while enhancing the quality of healthcare services in the region. Through its robust infrastructure and expertise, Region Västerbotten strives to drive scientific discovery and foster an environment of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Skellefteå, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported